ALSO NOTED: Ivax wins FDA approval; Reformulated Clarinex gains regulatory OK; Schwarz buys remaining rotigotine rights; and mu

> The FDA has given Miami-based Ivax final approval for hydrochlorothiazide capsules 12.5 mg. Release [1]

> The FDA has approved a reformulated version of Clarinex for allergies. Release [2]

> Analysts applauded news that Schwarz Pharma had bought out the remaining rights to rotigotine. Story [3]

> Dusa Pharmaceuticals reported lower-than-expected second quarter sales. Release [4]

And Finally... In a new paper in Science, researchers and ethicists discuss the potential ethical dilemmas surrounding the use of monkeys in testing brain cell therapy, such as creating a monkey with a human-like mind. Article [5]